Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease?
暂无分享,去创建一个
[1] E. Hoffman,et al. Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. , 2013, The Journal of clinical investigation.
[2] S. Randell,et al. Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[3] M. Althaus. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art. , 2013, Current molecular pharmacology.
[4] M. Butterworth,et al. Proteases, cystic fibrosis and the epithelial sodium channel (ENaC) , 2013, Cell and Tissue Research.
[5] T. Chinet,et al. Effect of nitric oxide on epithelial ion transports in noncystic fibrosis and cystic fibrosis human proximal and distal airways. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[6] D. Baines,et al. AMP‐activated protein kinase (AMPK)–dependent and –independent pathways regulate hypoxic inhibition of transepithelial Na+ transport across human airway epithelial cells , 2012, British journal of pharmacology.
[7] J. Sheehan,et al. Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways , 2012, Mucosal Immunology.
[8] C. Schultz,et al. CFTR Regulates Early Pathogenesis of Chronic Obstructive Lung Disease in βENaC-Overexpressing Mice , 2012, PloS one.
[9] M. Myerburg,et al. Activation of the Epithelial Sodium Channel (ENaC) by the Alkaline Protease from Pseudomonas aeruginosa* , 2012, The Journal of Biological Chemistry.
[10] D. Pearce,et al. Organization of the ENaC-regulatory machinery , 2012, Critical reviews in biochemistry and molecular biology.
[11] S. Matalon,et al. The CFTR and ENaC debate: how important is ENaC in CF lung disease? , 2012, American journal of physiology. Lung cellular and molecular physiology.
[12] T. Kleyman,et al. Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. , 2012, Experimental cell research.
[13] Y. Qadri,et al. ENaCs and ASICs as therapeutic targets. , 2012, American journal of physiology. Cell physiology.
[14] L. Palmer,et al. Regulation and dysregulation of epithelial Na+ channels , 2012, Clinical and Experimental Nephrology.
[15] L. Ostrowski,et al. Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[16] L. Bingle,et al. Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. , 2011, Biochemical Society transactions.
[17] C. Schultz,et al. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[18] D. Rotin,et al. Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease , 2011, Proceedings of the National Academy of Sciences.
[19] M. Welsh,et al. Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia , 2010, Cell.
[20] L. Bakaletz,et al. The Multifunctional Host Defense Peptide SPLUNC1 Is Critical for Homeostasis of the Mammalian Upper Airway , 2010, PloS one.
[21] Seiko F. Okada,et al. Human Alveolar Type II Cells Secrete and Absorb Liquid in Response to Local Nucleotide Signaling* , 2010, The Journal of Biological Chemistry.
[22] M. Gentzsch,et al. CFTR's Proteolysis Protection♦ , 2010, Journal of Biological Chemistry.
[23] S. Pradervand,et al. Airway Surface Liquid Volume Regulation Determines Different Airway Phenotypes in Liddle Compared with βENaC-overexpressing Mice* , 2010, The Journal of Biological Chemistry.
[24] N. Dokholyan,et al. Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases , 2010, Pflügers Archiv - European Journal of Physiology.
[25] D. Kentrup,et al. Characterization of the epithelial sodium channel delta-subunit in human nasal epithelium. , 2010, American journal of respiratory cell and molecular biology.
[26] J. Dötsch,et al. A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition , 2010, The Journal of physiology.
[27] M. Myerburg,et al. Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking. , 2010, American journal of respiratory cell and molecular biology.
[28] J. Olsen,et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage , 2009, Proceedings of the National Academy of Sciences.
[29] L. Koulischer,et al. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants. , 2009, Chest.
[30] M. Mall. Role of the amiloride‐sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease , 2009, Experimental physiology.
[31] N. Alexis,et al. Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? , 2008, American journal of physiology. Lung cellular and molecular physiology.
[32] D. Meyerholz,et al. Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.
[33] D. Silverthorn,et al. Insight toward epithelial Na+ channel mechanism revealed by the acid‐sensing ion channel 1 structure , 2008, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.
[34] R. Tarran,et al. Liquid movement across the surface epithelium of large airways , 2007, Respiratory Physiology & Neurobiology.
[35] D. Benos,et al. Molecular Proximity of Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel Assessed by Fluorescence Resonance Energy Transfer* , 2007, Journal of Biological Chemistry.
[36] S. Cross,et al. Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic Fibrosis , 2007, Respiratory research.
[37] A. Robay,et al. Regulatory interactions of N1303K-CFTR and ENaC in Xenopus oocytes: evidence that chloride transport is not necessary for inhibition of ENaC. , 2007, American journal of physiology. Cell physiology.
[38] M. Myerburg,et al. Airway Surface Liquid Volume Regulates ENaC by Altering the Serine Protease-Protease Inhibitor Balance , 2006, Journal of Biological Chemistry.
[39] R. Tarran,et al. Soluble Mediators, Not Cilia, Determine Airway Surface Liquid Volume in Normal and Cystic Fibrosis Superficial Airway Epithelia , 2006, The Journal of general physiology.
[40] S. Matalon,et al. δ-Subunit Confers Novel Biophysical Features to αβγ-Human Epithelial Sodium Channel (ENaC) via a Physical Interaction* , 2006, Journal of Biological Chemistry.
[41] D. Baines,et al. Forskolin-induced Cell Shrinkage and Apical Translocation of Functional Enhanced Green Fluorescent Protein-Human αENaC in H441 Lung Epithelial Cell Monolayers* , 2006, Journal of Biological Chemistry.
[42] M. Knowles,et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. , 2006, The New England journal of medicine.
[43] Richard C Boucher,et al. Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis , 2005, Journal of Biological Chemistry.
[44] R. Schreiber,et al. Cl– Interference with the Epithelial Na+ Channel ENaC* , 2005, Journal of Biological Chemistry.
[45] R. Boucher,et al. Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[46] D. Sheppard,et al. Transepithelial electrical measurements with the Ussing chamber. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[47] Richard C Boucher,et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice , 2004, Nature Medicine.
[48] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[49] R. Schreiber,et al. The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl− concentration , 2001, EMBO reports.
[50] J. Gatzy,et al. The Relative Roles of Passive Surface Forces and Active Ion Transport in the Modulation of Airway Surface Liquid Volume and Composition , 2001, The Journal of general physiology.
[51] R. Tarran,et al. The CF salt controversy: in vivo observations and therapeutic approaches. , 2001, Molecular cell.
[52] J. Pilewski,et al. Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[53] B. Stanton,et al. Gating of amiloride-sensitive Na(+) channels: subunit-subunit interactions and inhibition by the cystic fibrosis transmembrane conductance regulator. , 2000, Biophysical journal.
[54] P. Quinton,et al. Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function , 1999, Nature.
[55] R. Schreiber,et al. Cystic Fibrosis Transmembrane Conductance Regulator Inhibits Epithelial Na+ Channels Carrying Liddle’s Syndrome Mutations* , 1999, The Journal of Biological Chemistry.
[56] R. Schreiber,et al. The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Randell,et al. Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease , 1998, Cell.
[58] R. Schreiber,et al. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. , 1998, The Journal of clinical investigation.
[59] L. Schild,et al. A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel , 1997, The EMBO journal.
[60] L. Schild,et al. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. , 1996, The EMBO journal.
[61] J C Olsen,et al. CFTR as a cAMP-dependent regulator of sodium channels , 1995, Science.
[62] B. Abella,et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model , 1995, Nature Genetics.
[63] B. Grubb,et al. Ion transport across the jejunum in normal and cystic fibrosis mice. , 1995, The American journal of physiology.
[64] M. Konstan,et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. , 1994, American journal of respiratory and critical care medicine.
[65] C. Cotton,et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. Widdicombe,et al. Altered fluid transport across airway epithelium in cystic fibrosis. , 1993, Science.
[67] B. Koller,et al. An Animal Model for Cystic Fibrosis Made by Gene Targeting , 1992, Science.
[68] M. Yacoub,et al. Effect of heart-lung transplantation on airway potential difference in patients with and without cystic fibrosis. , 1991, The European respiratory journal.
[69] M. Knowles,et al. Evidence for reduced Cl‐ and increased Na+ permeability in cystic fibrosis human primary cell cultures. , 1988, The Journal of physiology.
[70] M. Knowles,et al. Oxygen Consumption and Ouabain Binding Sites in Cystic Fibrosis Nasal Epithelium , 1986, Pediatric Research.
[71] L. Cantley,et al. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. , 1986, The Journal of clinical investigation.
[72] M. Knowles,et al. Abnormal ion permeation through cystic fibrosis respiratory epithelium. , 1983, Science.
[73] M. Knowles,et al. Relative ion permeability of normal and cystic fibrosis nasal epithelium. , 1983, The Journal of clinical investigation.
[74] M. Knowles,et al. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. , 1981, The New England journal of medicine.
[75] H H USSING,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.
[76] H. Sticht,et al. A mutation in the β-subunit of ENaC identified in a patient with cystic fibrosis-like symptoms has a gain-of-function effect. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[77] D. Baines,et al. Cleavage of endogenous γENaC and elevated abundance of αENaC are associated with increased Na+ transport in response to apical fluid volume expansion in human H441 airway epithelial cells , 2011, Pflügers Archiv - European Journal of Physiology.
[78] S. Matalon,et al. Delta-subunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction. , 2006, The Journal of biological chemistry.
[79] Boxer,et al. An Animal Model , 2005 .
[80] A. Konstas,et al. cAMP-dependent activation of CFTR inhibits the epithelial sodium channel (ENaC) without affecting its surface expression , 2002, Pflügers Archiv.
[81] Ichael,et al. PULMONARY EPITHELIAL SODIUM-CHANNEL DYSFUNCTION AND EXCESS AIRWAY LIQUID IN PSEUDOHYPOALDOSTERONISM , 2000 .
[82] R. Boucher,et al. Pathophysiology of gene-targeted mouse models for cystic fibrosis. , 1999, Physiological reviews.
[83] J. Gatzy,et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. , 1996, Nature genetics.
[84] B. Abella,et al. Generation and characterization of a delta F508 cystic fibrosis mouse model. , 1995, Nature genetics.
[85] M. King,et al. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study. , 1991, Advances in experimental medicine and biology.
[86] M. Knowles,et al. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis. , 1987, The Journal of clinical investigation.
[87] J. A. Acree. On mutation , 1980 .
[88] E. Egan,et al. Changes in non‐electrolyte permeability of alveoli and the absorption of lung liquid at the start of breathing in the lamb. , 1975, The Journal of physiology.